Purpose The Composite International Diagnostic Interview-Short Form (CIDI-SF) is a short disorder-specific diagnostic interview for common mental disorders. Many researchers have been attracted to the CIDI-SF because of its brevity and cost effectiveness. As a result, the CIDI-SF has been used in multiple epidemiological studies and clinical trials. Despite the widespread use, a search of literature has revealed relatively few validation studies. This investigation aims to provide estimates of concordance and discordance between the CIDI-SF disorder modules and the full CIDI, as well as providing evidence regarding the potential screening utility of the CIDI-SF. Methods The sample comprised 83 patients attending a tertiary referral clinic for anxiety disorders. Patients were administered the CIDI-SF and the full CIDI-Auto and estimates of agreement between the two measures were calculated. Interview transcripts were examined for cases that disagreed on a diagnosis to elicit a likely reason for the lack of agreement between the two measures. Finally, the screening properties of the dimensionally scored CIDI-SF were calculated and compared with the Depression Anxiety Stress Scale. Results The CIDI-SF tended to overestimate the rate of diagnoses as evidenced by a high degree of false positives. However, the CIDI-SF exhibited favorable screening properties (ruling out non-disordered cases). Conclusions These results suggest that caution must be taken when using the CIDI-SF as the sole diagnostic instrument in epidemiological research to estimate prevalence and incidence. The CIDI-SF may be more useful for screening out potential candidates in clinical research and psychopharmacological trials.
Introduction
The Composite International Diagnostic Interview-Short Form (CIDI-SF) is a brief, disorder-specific, fully structured diagnostic interview. It was developed out of the need for quick and cost-effective psychiatric assessment in the annual US National Health Interview Survey [1] . The original CIDI-SF was developed using a stepwise regression technique with data from the National Co-morbidity Survey (NCS; [2] ) that estimated DSM-III-R prevalence. The aim of the measure was to maintain a small subset of items from the full Composite International Diagnostic Interview (CIDI), which appeared to be highly predictive of a diagnosis, to allow a substantial saving in time while maximizing the overall diagnostic accuracy [3] . The CIDI-SF has since undergone specific alterations and revisions to assess DSM-IV diagnoses.
Many researchers have been attracted to the CIDI-SF because of its brevity and cost effectiveness. Since its initial development, the CIDI-SF or variants of the original CIDI-SF have been used in a diverse range of settings for a variety of purposes. For instance, the Canadian National Population Health Survey has used the CIDI-SF to assess the prevalence of DSM-IV mood disorders in the general population [4] ; the HIV Cost and Services Utilization Study administered the CIDI-SF in a longitudinal study of persons receiving medical care for HIV [5] ; the Healthcare for Communities study used the CIDI-SF to rapidly assess the impact of health care delivery on psychiatric disorders [6] ; and many independent researchers have implemented the CIDI-SF to assist with the selection of a suitable sample for pharmacological trials and clinical research [7, 8] .
In epidemiological settings, it is paramount that a diagnostic tool estimates prevalence and incidence rates with a high degree of accuracy. Over-or underestimation of prevalence has critical implications for developing useful healthcare policy and assessing the population's need for mental health prevention and treatment programs [9] . In clinical research, a diagnostic tool may not require the same level of accuracy; however, the tool should at least adequately screen potential subjects so that researchers are confident that the desired sample is targeted [10, 11] . A critical question is whether the CIDI-SF has the level of accuracy required for use in epidemiological and clinical studies. A search of the literature has uncovered relatively few validation studies of the CIDI-SF and a firm conclusion regarding the validity of the interview is yet to be established.
Kessler et al. [3] were the first to show that the disorder modules of the CIDI-SF exhibited an excellent level of diagnostic agreement with the University of Michigan's version of the CIDI (UM-CIDI). The total classification accuracy ranged from 93.2% for depression to 99.9% for agoraphobia. However, since the CIDI-SF and UM-CIDI responses were elicited in a single interview, the authors stated that the concordance estimates ''represent partwhole associations between sets of responses to symptom questions collected in a single survey'' (p. 182). It was concluded that further independent validation, where both forms of the CIDI are administered separately, is required.
Patten [12, 13] investigated the performance of the CIDI-SF depression module in comparison to the full depression section of the CIDI version 2.1 (CIDI-Auto), administered independently from each other. In both community and clinical samples, they found that the CIDI-SF tended to overestimate the true prevalence rate and produced a high number of false positives. This suggests that the CIDI-SF is a highly sensitive instrument, but not very specific. The majority of false positives were due to the inadequacy of the CIDI-SF to assess the clinical significance of symptoms and their relationship to organic causes (i.e., due to a chronic physical condition, medication use or bereavement). Furthermore, it appeared that the CIDI-SF did not identify DSM-IV major depression in the strictest sense, but identified a broader category of depressive disorder. These findings have since been replicated in a sample of young adults using the Schedules for Clinical Assessment in Neuropsychiatry as the comparison interview [14] .
Finally, four modules of the CIDI-SF (depression, panic disorder, generalized anxiety disorder, dysthymia) were validated against the UM-CIDI in a representative sample of persons in care for HIV [15] . The results provided further evidence that the CIDI-SF was highly sensitive at detecting DSM-III-R diagnoses, but not very specific. The authors concluded that the CIDI-SF may be better suited for use as a valid disorder screener instead of a disorderspecific diagnostic tool. Burnam et al. [16] supported this conclusion and showed that the CIDI-SF scales were highly correlated to another screening measure of emotional health when predicting health service use. However, the high degree of physical co-morbidity observed in the sample of persons in care for HIV and the failure to validate the full range of CIDI-SF disorder modules against DSM-IV diagnoses has left a gap in the literature that requires further examination.
The current study aims to investigate the validity and diagnostic performance of all ten CIDI-SF modules in a clinical sample of adults who presented to a tertiary referral anxiety disorders clinic. According to previous literature, it was hypothesized that the CIDI-SF would identify more false positives in comparison to the full CIDI, predominantly due to a lack of items addressing the clinical significance of symptoms and their relationship with organic causes. Furthermore, previous literature has suggested that the CIDI-SF may be useful as a general screening measure for mood and anxiety disorders. Consequently, an additional aim was to directly compare the screening utility of the CIDI-SF with a well-developed general screening measure for mood and anxiety, the Depression Anxiety Stress Scale [17] . It was hypothesized that the CIDI-SF modules, used as dimensionally scored screening instruments, would possess similar screening properties to the DASS.
Method

Sample and setting
The sample comprised patients referred for treatment to a Sydney metropolitan anxiety disorders clinic between May 1999 and January 2000. During the 8-month period assigned for this study, a total of 325 patients were assessed at the clinic. Data for this study were collected from patients across two phases of assessment at the anxiety disorders clinic. CIDI-SF data were collected from 305 patients during their first day of assessment. The first day assessment is designed to screen patients and determine whether the treatment programs offered at the clinic are suitable for each patient. Those offered treatment were asked to return for a second day assessment approximately 3 weeks later when a comprehensive diagnosis was determined. It was at this point that CIDI-Auto data were collected on the 103 patients returning for their second day assessment. Due to some missing data on the CIDI-SF, matching CIDI-SF and CIDI-Auto data were limited to a subsample of 83 patients. All subsequent analyses were conducted on this subsample of patients. Post hoc comparisons were conducted on a range of demographic features and the type of CIDI-SF diagnoses received to confirm that this sample did not significantly differ from the remaining sample of patients who attended the clinic during this period. These comparisons revealed that, on average, the patients in the subsample were approximately 4 years younger than patients who were not included in this study 
Measures
CIDI-SF
Modifications and revisions were made to the original CIDI-SF [3] to make it suitable for assessing a probable DSM-IV 12-month diagnosis of common mental disorders. Social phobia, agoraphobia, panic attack, generalized anxiety disorder (GAD), major depressive episode (MDE), dysthymia, obsessive compulsive disorder (OCD), post-traumatic stress disorder (PTSD), alcohol dependence and drug dependence were assessed. To reduce respondent burden and total administration time further, the CIDI-SF utilizes a stem and branch method of screening patients. If the patient fails to endorse the screening questions, they skip the remaining questions associated with that particular disorder and proceed to the next module.
A probable diagnosis for each disorder is calculated by summing the number of symptom questions endorsed by the patient and applying empirically derived cutoffs, which were designed to maximize concordance with the full DSM-III-R diagnostic criteria (see [3] for a detailed description of how the empirically derived cutoff scores were estimated). The CIDI-SF assesses a probable and not a definite diagnosis, since the complete diagnostic criteria, such as the clinical significance and associated physical exclusion criteria, are not fully operationalized.
CIDI-Auto
The characteristics of the CIDI-Auto have been well described elsewhere [18] . Briefly, it is a fully-structured selfreport diagnostic interview administered via a computer to derive a 12-month diagnosis of the common DSM-IV and ICD-10 mental disorders. In contrast to the CIDI-SF, the CIDI-Auto extensively assesses each diagnostic criterion, including the symptom criteria and the associated levels of distress, severity, and impairment as well as the relevant exclusion criteria. A stem and branch system is implemented within the CIDI-Auto to reduce respondent burden. There are separate modules to determine the presence of MDE, dysthymia, social phobia, agoraphobia, panic disorder, GAD, OCD, PTSD, alcohol dependence and drug dependence in the previous 12 months.
It has been shown that the CIDI-Auto possesses adequate validity in comparison to fully structured and unstructured clinical interviews and excellent test-retest reliability across multiple settings [19] [20] [21] . The CIDI-Auto has been used extensively to estimate prevalence in nationally representative epidemiological surveys, for example the 1997 Australian National Survey of Mental Health and Well-being [22] . For these reasons, the CIDIAuto was chosen as the ''gold'' diagnostic standard in the current study when estimating the diagnostic validity of the CIDI-SF.
DASS
The Depression Anxiety Stress Scale (DASS) was developed to measure the full range of symptoms associated with depression and anxiety. It consists of 42 self-report items answered on a four-point scale where 0 indicates that the item does not apply to the respondent at all, while 3 indicates that the item applies very much to the respondent. Factor analyses have consistently identified three factors that translate into separate subscales representing depression, anxiety and stress [17] . Each of the three DASS subscales comprise 14 items. The responses to each of the 14 items are summed and a total score ranging from 0 to 42 is calculated for all three subscales.
The DASS has excellent internal consistency and favorable test-retest reliability in non-clinical and clinical samples [23] . Furthermore, the DASS is able to significantly differentiate between patients with panic disorder, GAD and mood disorders from other diagnostic groups [24] . The DASS is used here as the ''gold'' standard when examining the screening utility of the CIDI-SF. As the DASS was not intended to be a measure of the alcohol and substance use disorders, the alcohol and drug dependence modules were not included when investigating the screening utility of the CIDI-SF.
Procedure
During the first day of assessment, patients were given a written consent form to read and sign stating that any information collected during the diagnostic assessment could be used for research purposes and that publication of results would be in the de-identified format. Patients then completed a routine diagnostic assessment that included the DASS, CIDI-SF, the Medical Outcomes Study Short Form Health Survey (SF-12; [25] ) and a clinical interview with an experienced consultant psychiatrist. Patients who were offered treatment at the clinic for either anxiety (social phobia, panic disorder, agoraphobia, generalized anxiety disorder) or depression returned for a second, comprehensive diagnostic assessment, approximately 3 weeks later. Returning patients then completed the CIDIAuto via self-report computer administration. A research assistant was available if any patient required assistance with the CIDI-Auto.
Statistical analysis
Concordance analysis
To generate concordance estimates between the CIDI-SF and CIDI-Auto, each module was scored using algorithms that resulted in 12-month diagnostic variables. Each module was analyzed separately using 2 9 2 cross tabulations in SPSS version 17. Measures of diagnostic agreement including sensitivity, specificity, positive predictive value, negative predictive value, overall percentage of agreement and likelihood ratios were calculated to estimate the independent effect of both false positives and false negatives. However, despite the above indices providing valuable information regarding the level of agreement between the two measures, they do not take into account agreements that occur purely by chance.
To control for the level of chance agreements while maintaining information regarding the relative importance of both false positives and false negatives, weighted kappas (j-and j?) were also calculated [26] . Both indices produce scores ranging from 0 to 1. A low score on jindicates a high rate of false negatives, while a high score indicates a low rate of false negatives. Therefore, the diagnostic test will possess favorable properties for ruling out the disorder when j-approaches 1. On the other hand, a low score on j? indicates a high rate of false positives, while a high score indicates a low rate of false positives. Therefore, the diagnostic test will possess favorable properties for ruling in the disorder when j? approaches 1 [27] . To accurately interpret the magnitude of each kappa coefficient, Landis and Koch [28] suggest that there is excellent agreement when kappa exceeds 0.8, substantial agreement between 0.6 and 0.8, moderate agreement between 0.4 and 0.6 and poor agreement when kappa drops below 0.4.
Studies have shown that in some circumstances, kappa can be unduly influenced by the initial base prevalence rate of the disorder and therefore comparing two coefficients of separate disorders can be problematic [29, 30] . Furthermore, simulations studies have revealed that small kappa coefficients are possible when the percentages of agreement are high, therefore creating disparate results [31] [32] [33] . To overcome these issues, alternative indices should be generated that are not influenced by the base prevalence rate to clarify the results of kappa. Area under the receiver operating characteristic curve (AUC) was therefore calculated by summing the sensitivity with specificity and dividing by two. The AUC is interpreted as a score between 0.5 and 1.0 with larger values indicating a greater level of agreement between the two measures. According to Swets [34] , an AUC ranging from 0.5 to 0.7 indicates that the measure has low accuracy, 0.7-0.9 indicates a reasonably useful measure, and an AUC above 0.9 indicates a highly accurate measure.
Discordance analysis
One of the additional aims of the current study was to quantify the likely reasons for discordant results. Therefore, several possible reasons were ascribed as to why a discrepancy might occur between the two interviews prior to the analysis and each discrepant case was classified accordingly. For each disorder, the CIDI-Auto interview transcripts for false positives and false negatives were compared to the matching CIDI-SF questionnaires to isolate the likely reasons for a discordant result.
The predetermined classification groupings for the discordance analysis are as follows. The two interviews could totally disagree on a diagnosis as evident by a patient meeting the screening requirements for a disorder on one interview but not on the other. This category was labeled as total misclassification due to screening. A diagnostic disagreement could also occur when the two interviews agree on the majority of criteria, but the patient fails to receive a final diagnosis on one interview due a discrepancy in one or two key questions. Disagreements like this could be attributed to one of two reasons. The first reason is that the diagnostic discrepancy is the result of differences between the patient's pattern of responding. For example, the patient may fail to meet full criteria for a disorder using the CIDI-Auto, but meets criteria in the CIDI-SF, by providing two different responses to the same question included in both interviews. The second reason is that the diagnostic discrepancy is the results of differences between the two interviews. For example, the patient may fail to meet full criteria for a disorder using the CIDI-Auto, but meet criteria using the CIDI-SF, by providing a response to a question that was included in the CIDI-Auto but was removed from the CIDI-SF. These two categories were labelled as ''partial agreement-patient response disagreement'' and ''partial agreement-measure response disagreement'', respectively.
Finally, investigating cases with partial agreement allows the discrepancy between the two interviews to be isolated to a specific reason or component of the DSM-IV criteria. Therefore, three specific reasons for disagreement were included in cases with partial agreement. These reasons include: not meeting the required symptom criteria and/or diagnostic thresholds, insufficient levels of severity/ distress/interference related to the disorder, and finally not meeting the common exclusion criteria (i.e., physical/ medical reasons attributed to symptom, or a co-occurring diagnosis that better explains the symptoms).
Screening utility
As a means of estimating the screening utility of the CIDI-SF, the screening properties of the CIDI-SF were compared with the DASS when predicting a CIDI-Auto diagnosis. First, the CIDI-SF was re-scored similar to a screening instrument by using the sum of the total symptoms endorsed for each disorder rather than generating diagnostic variables using empirically derived cut points. Each disorder module was scored using a continuous scale that ranges from 0 to the maximum number of symptoms in each module, so that higher scores indicate a higher probability of having the disorder.
Second, receiver operating characteristic (ROC) curves were fitted to each CIDI-Auto disorder separately using the CIDI-SF and the DASS as predictor variables. The ROC curve plots the sensitivity and 1 minus the specificity for every possible cutoff point on the CIDI-SF and DASS. The AUC values associated with each ROC curve are able to estimate the screening tool's ability to accurately predict a diagnosis [35] . For each disorder, the two AUC values and 95% confidence intervals were estimated using nonparametric methods and compared using a technique described by Delong, Delong and Clarke-Pearson [36] . This technique results in a v 2 difference test, so that rejecting the null hypothesis at the nominal 0.05 level indicates that one screening tool has significantly greater predictive power than the other.
Results
Sample characteristics
This study assessed 83 patients with a mean age of 32 years and a range from 18 to 54 years; 70% of the patients were female. The sample was, as expected, highly disordered with approximately 88% diagnosed by the CIDI-Auto with an anxiety disorder, 42% with a mood disorder, and 20% with one form of substance dependence present in the previous 12 months. The rate of co-morbid diagnoses was high, with two diagnoses observed as the median and a range from 0 to 7. The average level of disability attributed to the patient's mental health was 34, as measured by the SF-12, a score that is consistent with treatment-seeking clinical populations [37] . Due to missing data, some patients were excluded from analyses of specific modules.
Concordance analysis
The results of the concordance analysis are presented in Table 1 . The CIDI-SF consistently diagnosed patients at a higher rate than the CIDI-Auto with the largest discrepancies occurring between the agoraphobia (47.5 vs. 3.8%) and OCD modules (60.2 vs. 13.3%). The weighted kappa coefficients reveal that for all disorders, apart from OCD, the j-values are within the moderate to excellent range indicating that the CIDI-SF produces relatively few false negatives and possesses favorable properties for ruling out disorders. On the other hand, the j? values are within the poor range for all disorders indicating a large number of false positives and that the CIDI-SF possesses undesirable properties for ruling in disorders. The AUC values support the kappa coefficients by providing evidence that dysthymia, OCD and social phobia modules have poor diagnostic agreement with the CIDI-Auto, but the remaining modules can be considered as reasonably useful screening measures. No disorder module scored an AUC value within the excellent range. This is most likely due to the large number of false positives.
Discordance analysis
The results of the discordance analysis are presented in Table 2 . The primary reason for false positive and false negative results differed depending on the disorder under investigation. The few false negatives examined in the discordance analysis were predominantly due to total misclassification between the screening questions. For example, of the seven false negative cases observed in panic disorder, five (71%) were due to failing the CIDI-SF screening question, but met the full criteria on the CIDI-Auto, and two (29%) partially agreed on a diagnosis, yet the patients disagreed on symptom questions contained in both the CIDI-SF and CIDI-Auto.
It is of interest to note that for false positive results, apart from OCD and dysthymia, the CIDI-SF and CIDI-Auto partially agreed on most cases ([50%). This indicates that the CIDI-SF possibly detects cases that have some degree of disorder but are considered subthreshold by the CIDI-Auto. The only disorder to show a large proportion of false positive cases due to the exclusion criteria was agoraphobia with 66% of cases. These cases tended to fail a CIDI-Auto diagnosis because their symptoms were better explained by panic disorder, while this requirement was not incorporated into the diagnostic algorithms for the CIDI-SF.
All the false positives identified in the dysthymia module were due to total misclassification between the screening items. This may be due to the inability of the CIDI-SF dysthymia screening questions to adequately screen out non-disordered patients in comparison to the screening questions for the CIDI-Auto. The false positives in the remaining disorder modules were due to a mix of failing the symptom and/or threshold criteria, or because the symptoms endorsed did not meet the clinical significance and distress requirements of the CIDI-Auto. In cases with partial agreement, the cause of the disagreement was split between differing patient responses and differences in the two interviews, except for the depression module, where all of the partial agreement cases (65% of all false positive cases) were due to differences between the two interviews.
Screening utility
The AUC values, 95% confidence intervals and v 2 difference tests comparing the CIDI-SF disorder modules and the DASS subscales predicting CIDI-Auto diagnoses are presented in Table 3 . The AUC values for the majority of disorders are within the acceptable range except for the CIDI-SF module predicting dysthymia (AUC = 0.63), the DASS-Anxiety scale predicting social phobia (AUC = 0.50) and the DASS-Anxiety scale predicting OCD (AUC = 0.54). The data provide no evidence that the CIDI-SF modules differ in terms of predictive power to the DASS subscales when identifying MDE, dysthymia, GAD, panic disorder, PTSD and agoraphobia. However, for a diagnosis of social phobia or OCD, it appears that the CIDI-SF has a significantly higher predictive power in comparison to the DASS-Anxiety scale, with v 2 = 8.09, p = 0.005 and v 2 = 22.27, p \ 0.001, respectively.
Discussion
The primary aim of the current study was to investigate the validity and level of diagnostic concordance between the CIDI-SF and the full CIDI-Auto in a sample of patients attending a tertiary referral anxiety disorders clinic. Secondary aims included quantifying the level of discordance and investigating the screening properties of the CIDI-SF. The results of the study confirmed the hypothesis that the CIDI-SF would generate an undesirable proportion of false positives when compared with the CIDI-Auto. This finding provides additional support to previous literature [4, 12, 14, 15] . However, the suggestion that false positives were primarily due to the lack of questions assessing the influence of medication and co-morbid physical conditions is unfounded. This is perhaps not surprising given that a previous study has suggested that the physical exclusion criteria have little influence on estimating overall prevalence rates when they are removed from the CIDI-Auto Cases with missing data on CIDI-SF disorder modules were excluded Table 2 Reasons for discordance between CIDI-SF and CIFI-Auto modules for common mental disorders algorithms [38] . Instead, the false positive cases were better explained by a variety of reasons that included insufficient screening questions, inaccurate symptom thresholds and a failure to assess clinically significant levels of distress. Finally, the results of the current study confirmed the hypothesis that the CIDI-SF possesses good screening properties in comparison to a valid general screening measure for anxiety and depression. In fact, the CIDI-SF exhibited significantly better screening properties for social phobia and OCD in comparison to the DASS.
The findings of the current study raise several important points for discussion. It is of some value to understand why the results presented in the current study are different from those previously found by Kessler et al. [3] . There are two possible explanations for the different results. First, it is a well-established fact that clinical respondents often differ in their pattern and degree of responding to diagnostic instruments in comparison to community samples [39] . It is therefore difficult to accurately compare and generalize the findings of this study to epidemiological samples. The high degree of false positives demonstrated here may be isolated to a highly disordered treatment-seeking clinical population where the prevalence rates of these disorders are higher than those observed in the general population. Fortunately, we can use the likelihood ratio statistics to model the performance of the CIDI-SF using the base prevalence rates found in the 1997 Australian National Survey of Mental Health and Well-being [40] . For instance, the 12-month prevalence for major depressive episode in the Australian survey was 6.3%, and using the likelihood ratio generated from the current sample we would expect the CIDI-SF prevalence to be in the range of 55%, a dramatic overestimation. Similar results were observed for the remaining disorders suggesting that the clinical sample used in the current study may have exaggerated the level of discordance between the two instruments. On the other hand, evidence from Patten et al. [4] suggests that the CIDI-SF depression module likewise identified a high degree of false positives in a community sample of the Canadian general population, although not as high as those observed in the current study. The second, and more likely explanation, involves the use of different methodologies. Kessler et al. [3] calculated the degree of concordance by comparing responses to the CIDI-SF that were embedded within the full CIDI; thus, the two interviews were not administered independently. This has the serious implication of artificially inflating the true level of concordance, as it does not take into account the influence that prior questioning has on priming responses and establishing the correct context. Survey questionnaires undergo comprehensive cognitive testing during development to address any respondent misunderstandings and to confirm that the questions assess the desired construct using the proper context and format [41] . Shifting the order or removing certain questions can influence the respondents' understanding of the questionnaire as a whole and may cause differential response patterns [42] .
The next critical issue that requires discussion is how the CIDI-SF can be altered or calibrated to increase the level of accuracy in relation to the full CIDI. Epidemiological studies that quote prevalence estimates derived from the CIDI-SF run the risk of overestimating the true prevalence and identifying cases with a broader degree of psychopathology. Fortunately, methods to correct for this overestimation have been developed by adjusting the prevalence post hoc and have proven to be effective [43] . Alternatively, for studies that are yet to use the CIDI-SF, it may be advantageous to include additional questions addressing problematic areas identified by the current study. For example, the CIDI-SF dysthymia module had 23 false positive cases, all due to the failure of the CIDI-SF screening questions to adequately rule out non-disordered cases. After examination of the CIDI-Auto transcripts, it was concluded that if the CIDI-SF included one additional question from the CIDI-Auto, designed to screen out individuals with prolonged feelings of sadness and depression lasting 2 years or more without an interruption of 2 months of feeling well, then the level of false positives may decrease. However, this is assuming that the majority of cases will respond to questions in the CIDI-SF and CIDI-Auto in the same manner; therefore, re-classifying all 23 cases is considered the best case scenario.
The final point for discussion involves the capacity of the CIDI-SF to act as a general screening measure for anxiety and depressive disorders in a clinical setting, particularly when using the CIDI-SF to screen patients for potential disorder-specific CBT treatments and psychopharmacological trials. The findings of the current study demonstrate an interesting phenomenon that the majority of false positive cases ([50%) have some degree of disorder (i.e., the presence of some symptoms, mild levels of distress, etc.); however, they fail to meet full diagnostic criteria due to one or two specific reasons (i.e., fail to meet the full symptom threshold, lack clinically significant levels of distress). In a clinical sense this has some key advantages: one, it is important that true positive cases are not left undetected as greater weight is given to reducing false negatives instead of false positives; two, it has been shown that detecting and treating subthreshold cases may be an important first step in preventing a full episode from developing [44, 45] . Given that the CIDI-SF has adequate screening properties, the current study provides evidence that the CIDI-SF may be better suited as a short screening tool in clinical settings than for use in large-scale community epidemiological studies. Indeed, Orlando et al. [43] came to a similar conclusion when examining the performance of the CIDI-SF to screen for respondents at high risk for a psychiatric disorder in a population of HIV-positive adults.
The findings of the current study must be considered in relation to some of the relevant limitations. The moderate sample size used in the study is of some concern, particularly when comparing AUC values. The wide 95% confidence intervals around some of the AUC values indicate the possibility of inadequate statistical power and could have increased the risk of type II error. However, as the study used a clinical sample to generate the concordance estimates, we are confident that there are sufficient cases with and without diagnoses of the examined disorders to make meaningful conclusions. As mentioned above, the use of a clinical sample does carry further limitations when attempting to generalize the findings to a community sample. Therefore, additional validation of the full range of CIDI-SF modules is required to confirm that the findings found here are not specific to a subset of highly disordered treatment-seeking individuals.
Another limitation of the current study was that the order of administration of the CIDI-SF and CIDI-Auto was not randomized and that the CIDI-SF was administered prior to the CIDI-Auto in all cases. As mentioned above, self-report questionnaires are susceptible to order effects and the results of the CIDI-Auto may be unduly influenced by the outcome of the CIDI-SF as patients attempt to remain consistent. Although, this effect may be somewhat reduced due to the gap between interview administrations of approximately 3 weeks and therefore some patients may not recall their specific responses to the CIDI-SF. The gap in administration can likewise have an effect on the results due to changes in pathology over time; however, once again this effect may be reduced due to the 12-month time frame of the CIDI-SF and CIDI-Auto questions. The gap in administration time would have a greater effect if the interviews assessed the disorders as present in the prior 30 days.
Conclusions
The current study is the first to provide DSM-IV diagnostic agreement data between the full range of CIDI-SF disorder modules and the associated disorder sections of the CIDIAuto in a clinical population. The results highlight the importance of independent validation studies for short form diagnostic instruments and the potential risks that can occur when researchers rely on concordance estimates that are derived using the same sample from which it was constructed. The results indicate that the CIDI-SF possesses favorable properties for ruling out disorders, but undesirable properties for ruling in disorders. Consequently, the CIDI-SF is at risk of overestimating the true prevalence of mental disorders and therefore caution should be taken when the CIDI-SF is used as the sole diagnostic instrument in epidemiological studies. On the other hand, the CIDI-SF does appear to be a valid diagnostic screening instrument that can detect mental disorders at the threshold and to some degree at the subthreshold level. Therefore, for clinical research and psychopharmacological trials, the CIDI-SF is a valid tool for screening potential candidates.
